- Q2 2024 Corcept Therapeutics Inc Earnings Call TranscriptJul 29, 2024$36.53 (+2.61%)Earnings
- Q1 2024 Corcept Therapeutics Inc Earnings Call TranscriptMay 01, 2024$23.88 (+2.40%)Earnings
- Q4 2023 Corcept Therapeutics Inc Earnings Call TranscriptFeb 15, 2024$24.46 (+1.07%)Earnings
- Q3 2023 Corcept Therapeutics Inc Earnings Call TranscriptNov 01, 2023$28.09 (+0.04%)Earnings
- Q2 2023 Corcept Therapeutics Inc Earnings Call TranscriptAug 02, 2023$25.01 (+0.04%)Earnings
- Q1 2023 Corcept Therapeutics Inc Earnings Call TranscriptMay 03, 2023$23.1 (+3.17%)Earnings
- Q4 2022 Corcept Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$20.83 (-0.53%)Earnings
- Q3 2022 Corcept Therapeutics Inc Earnings Call TranscriptNov 03, 2022$28.52 (-1.11%)Earnings
- Q2 2022 Corcept Therapeutics Inc Earnings Call TranscriptAug 03, 2022$28.71 (+2.54%)Earnings
- Q1 2022 Corcept Therapeutics Inc Earnings Call TranscriptMay 05, 2022$21.32 (-4.05%)Earnings
- Corcept Therapeutics Inc Ovarian Cancer Program Update TranscriptMar 31, 2022
- Q4 2021 Corcept Therapeutics Inc Earnings Call TranscriptFeb 15, 2022$20.31 (+4.21%)Earnings
- Q3 2021 Corcept Therapeutics Inc Earnings Call TranscriptNov 03, 2021$18.24 (+1.22%)Earnings
- Q2 2021 Corcept Therapeutics Inc Earnings Call TranscriptJul 29, 2021$20.29 (-0.54%)Earnings
- Corcept Therapeutics Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- Q1 2021 Corcept Therapeutics Inc Earnings Call TranscriptMay 06, 2021$21.71 (+0.23%)Earnings
- Preliminary Q4 2020 Corcept Therapeutics Inc Earnings Call and Corporate Update TranscriptFeb 08, 2021$30.56 (+3.91%)Earnings
- Q2 2020 Corcept Therapeutics Inc Earnings Call TranscriptAug 04, 2020$15.69 (+2.21%)Earnings
- Q1 2020 Corcept Therapeutics Inc Earnings Call TranscriptMay 04, 2020$12.69 (+4.02%)Earnings
- Q4 2019 Corcept Therapeutics Inc Earnings Call TranscriptFeb 20, 2020$13.66 (-1.30%)Earnings
- Q3 2019 Corcept Therapeutics Inc Earnings Call TranscriptNov 07, 2019$14.6 (+2.46%)Earnings
- Q2 2019 Corcept Therapeutics Inc Earnings Call TranscriptAug 01, 2019$10.96 (-2.66%)Earnings
- Q1 2019 Corcept Therapeutics Inc Earnings Call TranscriptMay 09, 2019$11.41 (-4.92%)Earnings
- Q4 2018 Corcept Therapeutics Inc Earnings Call TranscriptFeb 25, 2019Earnings
Q1 2021 Corcept Therapeutics Inc Earnings Call Transcript
Good day, and welcome to the Corcept Therapeutics Conference Call. Today's conference is being recorded. (Operator Instructions)
At this time, I'd like to turn the conference over to Atabak Mokari. Please go ahead.
Good afternoon. I'm Atabak Mokari, Corcept's Chief Financial Officer. Today, we issued 3 press releases: one, announcing the positive outcome of our 178-patient Phase II trial of relacorilant in combination with nab-paclitaxel to treat patients with platinum-resistant ovarian cancer.
Second, announcing markedly decreased liver fat in patients in our Phase II trial of miricorilant as a potential treatment for nonalcoholic steatohepatitis of NASH; and the third, providing a clinical update and announcing our financial results for the first quarter. Copies of all of these are available at corcept.com. Our complete financial results will be available when we file our Form 10-Q with the SEC.
Today's call is being recorded. A replay will be available on the Investors Past
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)